Cargando…

Incidence and risk factors of pneumococcal pneumonia in adults: a population-based study

BACKGROUND: Infection caused by Streptococcus pneumoniae, mainly invasive pneumococcal disease (IPD) and pneumococcal pneumonia (PP), are a major public health problem worldwide. This study investigated population-based incidence and risk of PP among Catalonian persons ≥ 50 years-old with and withou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ochoa-Gondar, Olga, Torras-Vives, Verónica, de Diego-Cabanes, Cinta, Satué-Gracia, Eva M., Vila-Rovira, Angel, Forcadell-Perisa, María J., Ribas-Seguí, Domingo, Rodríguez-Casado, Clara, Vila-Córcoles, Angel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251659/ https://www.ncbi.nlm.nih.gov/pubmed/37291502 http://dx.doi.org/10.1186/s12890-023-02497-2

Ejemplares similares

Evaluating clinical effectiveness and impact of anti-pneumococcal vaccination in adults after universal childhood PCV13 implementation in Catalonia, 2017–2018
por: Vila-Córcoles, Angel, et al.
Publicado: (2023)

Epidemiología de la neumonía neumocócica en adultos mayores de 50 años: estudio de cohortes en Cataluña, 2017-2018
por: Ochoa-Gondar, Olga, et al.
Publicado: (2023)

Development of a predictive prognostic rule for early assessment of COVID-19 patients in primary care settings
por: Vila-Corcoles, Angel, et al.
Publicado: (2021)

Pneumococcal vaccination coverages by age, sex and specific underlying risk conditions among middle-aged and older adults in Catalonia, Spain, 2017
por: Vila-Córcoles, Angel, et al.
Publicado: (2019)

COVID19-related and all-cause mortality risk among middle-aged and older adults across the first epidemic wave of SARS-COV-2 infection: a population-based cohort study in Southern Catalonia, Spain, March–June 2020
por: Vila-Corcoles, Angel, et al.
Publicado: (2021)

Vacunación antineumocócica en adultos de Cataluña: coberturas y grado de adecuación a distintas guías de recomendaciones
por: Ochoa-Gondar, Olga, et al.
Publicado: (2018)

Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up
por: Vila-Corcoles, Angel, et al.
Publicado: (2012)

Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study
por: Vila-Corcoles, Angel, et al.
Publicado: (2018)

Susceptibility and risk of SARS-COV-2 infection among middle-aged and older adults in Tarragona area, Spain
por: Satué-Gracia, Eva M., et al.
Publicado: (2022)

Susceptibility and risk of SARS-COV-2 infection among middle-aged and older adults in Tarragona area, Spain
por: Satué-Gracia, Eva M., et al.
Publicado: (2022)

Influence of prior comorbidities and chronic medications use on the risk of COVID-19 in adults: a population-based cohort study in Tarragona, Spain
por: Vila-Córcoles, Angel, et al.
Publicado: (2020)

Rationale and design of the CAPAMIS study: Effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke
por: Vila-Corcoles, Angel, et al.
Publicado: (2010)

Utilidad de la escala de severidad modificada CRB75 en el manejo del paciente anciano con neumonía adquirida en la comunidad()
por: Ochoa Gondar, Olga, et al.
Publicado: (2013)

Prevalence of high, medium and low-risk medical conditions for pneumococcal vaccination in Catalonian middle-aged and older adults: a population-based study
por: Ochoa-Gondar, O., et al.
Publicado: (2017)

Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
por: Vila-Corcoles, Angel, et al.
Publicado: (2010)

Enfermedad neumocócica en el adulto: niveles de riesgo y recomendaciones de vacunación
por: Vila-Córcoles, Angel, et al.
Publicado: (2017)

The burden of community-acquired pneumonia in the elderly: the Spanish EVAN-65 Study
por: Ochoa-Gondar, Olga, et al.
Publicado: (2008)

Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up
por: Vila-Córcoles, Angel, et al.
Publicado: (2006)

Indicadores pronósticos de la COVID-19 en atención primaria
por: Satué Gracia, Eva María, et al.
Publicado: (2022)

Pneumococcal vaccination in times of COVID-19()
por: Vila Córcoles, Ángel
Publicado: (2022)

Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia
por: Vila-Corcoles, Angel, et al.
Publicado: (2009)

Vacunación antineumocócica en tiempos de COVID-19
por: Vila Córcoles, Ángel
Publicado: (2022)

Pneumococcal pneumonia
por: Goldblatt, David, et al.
Publicado: (2020)

Differences in Homing Potentials of Streptococcus pneumoniae–Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations
por: Palkola, Nina V., et al.
Publicado: (2015)

Value of pneumococcal PCR in respiratory samples for exclusion of pneumococcal pneumonia
por: Van Goethem, Sam, et al.
Publicado: (2023)

Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2017)

Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderly
por: Kislaya, Irina, et al.
Publicado: (2019)

Pneumonias in Glasgow and Their Pneumococcal Types
por: Grant, Margaret H.
Publicado: (1922)

Pneumococcal Pneumonia---Risky Business
Publicado: (2014)

Animal Models of Pneumococcal pneumonia
por: Borsa, Noemi, et al.
Publicado: (2019)

Neutrophil Recruitment in Pneumococcal Pneumonia
por: Palmer, Catherine S., et al.
Publicado: (2022)

Kinase Activity Profiling of Pneumococcal Pneumonia
por: Hoogendijk, Arie J., et al.
Publicado: (2011)

Is Ordinary (Pneumococcal) Pneumonia an Infectious Disease?
por: Buist, A. W. T.
Publicado: (1908)

The Incidence of Pneumococcal Types in Pneumonia in Assam
por: Napier, L. Everard, et al.
Publicado: (1935)

Epididymitis associated with bacteremic pneumococcal pneumonia
por: Berlinrut, Ilan, et al.
Publicado: (2021)

Bacteremic pneumococcal pneumonia: arrhythmogenic disease
por: Fernandez, Leyre Serrano, et al.
Publicado: (2022)

Comparison of the clinical features of invasive pneumococcal disease with those of pneumococcal pneumonia in adults
por: Kuroki, Akane, et al.
Publicado: (2022)

P18 Value of pneumococcal PCR in respiratory samples for exclusion of pneumococcal pneumonia
por: Van Herendael, Bruno, et al.
Publicado: (2023)

Clinical and Microbiological Factors Associated with High Nasopharyngeal Pneumococcal Density in Patients with Pneumococcal Pneumonia
por: Alpkvist, Helena, et al.
Publicado: (2015)

2717. The Impact of Pneumococcal Conjugate Vaccine in Nonbacteremic Pneumococcal Pneumonia Among Cancer Patients
por: Lee, Yeon Joo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bbj2aj44l0304t7rar9g0ifii8